SoftBank’s Vision Fund is continuing its aggressive dealmaking spree with plans to lead a $150 million investment round into a clinical trial startup called Science 37, Recode has learned.

The Vision Fund is in late talks to give new cash to the telemedicine company that helps researchers find participants for medical trials, according to people familiar with the deal. The transaction would value the company at about $300 million, not including the new money, the people said. [ Re/Code ]